Fluticasone/Umeclidinium/Vilanterol Inhalation Powder | Study Design

Regulatory Body	FDA
Study Drug Information	Test Product	Reference Product
Strength	Fluticasone furoate / Umeclidinium / Vilanterol 100/62.5/25 mcg 200/62.5/25 mcg	TRELEGY ELLIPTA 100/62.5/25 mcg 200/62.5/25 mcg
Formulation	Inhalation powder	Inhalation powder
Manufacturer	Any Sponsor	GSK
Route	Oral Inhalation	Oral Inhalation
Therapeutic Indication	Therapeutic class: Respiratory Drug class: • Fluticasone furoate: inhaled corticosteroid (ICS) • Umeclidinium: anticholinergic • Vilanterol: a long-acting β2 agonist (LABA) Therapeutic indication: Asthma, or severe COPD

View our other Services

Learn how BioPharma Services can be your trusted clinical trial partner.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.